PreComb

📍 Hombrechtikon, Switzerland🗓 Founded 2018👥 12 employees💰 Last funded Jul 2024
Biotechnology Research🌐 precomb.com
Website LinkedIn
PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer diagnostic to improve cancer management. It’s automated microtumor-based 3DTwin™ technology enables clinical institutions to integrate the technology on-site in the hospital. The test makes it possible to functionally evaluate multiple cancer drugs, drug combinations and drug concentrations directly on patient-derived micro-tumors to maximize treatment outcome.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in PreComb?
PreComb has 2 investors on record on gritt.io and 2 late-stage investors.
When did PreComb last raise funding?
The most recent investment in PreComb recorded on gritt.io was in July 2024.
When was PreComb founded?
PreComb was founded in 2018.
What industry is PreComb in?
PreComb operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is PreComb based?
PreComb is headquartered in Hombrechtikon, Switzerland.